MOVING INTELLIGENT CHANGE FORWARD
|
|
Buzzwords for 2020: biomarkers, digital health, data sharing, transparency, predictive analytics, AI, primary care, social determinants of health, mental health, healthy workplaces. How do they all intersect? Easy: the needs of the whole patient. Whether we’re trying to parse customized approaches to treating chronic disease or use data and modern technology to predict (and prevent) the next epidemic or trend of poor outcomes, initiatives in these areas have enormous potential. The challenge is achieving the positive benefit while minimizing the risk to privacy, exploitation, and incentives that have nothing to do with the health of our citizenry. I’m proud to work with organizations that seek change, but do so with integrity and a vigilant focus on benefiting patients. Here’s hoping this decade gives rise to individual organizations (and industries) that act with transparency and authenticity to benefit patients.
|
|
Health Conundrum: How State Budgets Can Find The Balance Between Social Versus Medical Services
|
Can the United States bring down overall health care costs by spending more on education, social services, and the other so-called social determinants of health? Substantial research has shown a clear link between social factors and health status, and there is some evidence that spending on these factors is also linked to improved health.
|
|
|
Rethinking Patient Data Privacy In The Era Of Digital Health
|
Over the past 10 years, US health care has gradually shifted toward digital record keeping in the professional realm—the world of hospitals, health plans, and physician practices. That transition occurred under the umbrella of privacy and security rules rooted in the Health Insurance Portability and Accountability Act of 1996 (HIPAA), a law which predates most modern online and mobile services, and explicitly excludes health information created or managed by patients themselves.
|
|
|
Managing the Most Expensive Patients
|
When corporate executives, health care leaders, and policy makers discuss the challenge of curbing U.S. health care costs, the conversation invariably turns to the sickest 5% of the population, who consume 50% of health care spending. For a long time the hope has been that improving the efficiency and quality of their treatment would significantly reduce the $3.5 trillion that the United States lays out annually for health care.
|
|
|
The debate over America’s drug-pricing system is built on myths. It’s time to face reality
|
America’s drug-pricing system is broken. Any system in which the list price of insulin triples in a decade, leading patients to ration it and sometimes die, is not working. Cancer patients should not worry that their disease will bankrupt them. The U.S. insurance system, which has instead gone decades without making tough decisions about how to pay for medicines, should not be passing on so many costs to patients.
|
|
|
What will 2020 bring for medicine and science? We asked 16 leaders for predictions
|
Last year, when we asked science and health care soothsayers to peek ahead to 2019, they told us that methamphetamine use would rise (it did), tumor organoids would near clinical use for personalizing cancer treatment and better targeting clinical trials (that’s happening), and price transparency wouldn’t bring lower health spending (that’s true, too).
|
|
|
A new biotechnology and pharmaceutical industry commitment to patients and the public
|
We, the undersigned leaders in the biotechnology and pharmaceutical industries, academia, and life science investors, recognize that at this pivotal moment in the history of our industry we are at the dawn of a golden age of medicine. We will soon have the ability to treat and cure diseases that have long been untreatable and incurable.
|
|
|
Passion + Quality = Change That Matters
I embrace the powerful opportunities in our evolving health care landscape. I founded Momentum Health Strategies to be a catalyst for change through continuous learning, diverse engagement and thoughtful policy and practice initiatives. I deliver innovative, strategic thinking and a passion for improving the patient experience. My personal drive and dedication to high-quality results will help you navigate the competitive terrain you face and convert your vision to action.
|
|
Momentum Health Strategies
Jennifer L Bright, MPA
(703) 628 - 0534
|
|
|
|
|
|
|
